75 related articles for article (PubMed ID: 20546260)
41. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
Peyrot M; Rubin RR; Lauritzen T; Skovlund SE; Snoek FJ; Matthews DR; Landgraf R; Kleinebreil L;
Diabetes Care; 2005 Nov; 28(11):2673-9. PubMed ID: 16249538
[TBL] [Abstract][Full Text] [Related]
42. Patients' Experiences with and Attitudes towards a Diabetes Patient Web Portal.
Ronda MC; Dijkhorst-Oei LT; Rutten GE
PLoS One; 2015; 10(6):e0129403. PubMed ID: 26086272
[TBL] [Abstract][Full Text] [Related]
43. What primary care physicians think about insulin initiation in type 2 diabetes: a field-based study.
Ak M; Sucakli MH; Canbal M; Koşar Y
Turk J Med Sci; 2015; 45(2):409-15. PubMed ID: 26084135
[TBL] [Abstract][Full Text] [Related]
44. Factors associated with psychological insulin resistance in individuals with type 2 diabetes.
Nam S; Chesla C; Stotts NA; Kroon L; Janson SL
Diabetes Care; 2010 Aug; 33(8):1747-9. PubMed ID: 20435797
[TBL] [Abstract][Full Text] [Related]
45. Patient barriers to insulin: The InfoCRIne order.
Kalra S
J Pak Med Assoc; 2018 Mar; 68(3):494-496. PubMed ID: 29540897
[TBL] [Abstract][Full Text] [Related]
46. Attitudes and beliefs of South African primary healthcare practitioners on initiating insulin in people with type 2 diabetes: Findings from the Tshwane Insulin Project (TIP).
Ngassa Piotie P; Wood P; Muchiri JW; Webb EM; Rheeder P
Prim Care Diabetes; 2021 Oct; 15(5):865-870. PubMed ID: 34167905
[TBL] [Abstract][Full Text] [Related]
47. Determination of attitude and knowledge of type 2 diabetic patients towards insulin therapy in Northern Cyprus.
Yilmaz UD; Tarhan S
J Pak Med Assoc; 2017 Mar; 67(3):343-349. PubMed ID: 28303979
[TBL] [Abstract][Full Text] [Related]
48. Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review.
Sparre T; Hammershøy L; Steensgaard DB; Sturis J; Vikkelsøe P; Azzarello A
J Diabetes Sci Technol; 2023 Mar; 17(2):290-301. PubMed ID: 36540004
[TBL] [Abstract][Full Text] [Related]
49. Development and evaluation of an online questionnaire to identify women at high and low risk of developing gestational diabetes mellitus.
Di Filippo D; Bell C; Chang MHY; Darling J; Henry A; Welsh A
BMC Pregnancy Childbirth; 2022 Apr; 22(1):321. PubMed ID: 35421942
[TBL] [Abstract][Full Text] [Related]
50. The Barbados Insulin Matters (BIM) study: Barriers to insulin therapy among a population-based sample of people with type 2 diabetes in the Caribbean island of Barbados.
Taylor CG; Taylor G; Atherley A; Hambleton I; Unwin N; Adams OP
J Clin Transl Endocrinol; 2017 Jun; 8():49-53. PubMed ID: 29067259
[TBL] [Abstract][Full Text] [Related]
51. Cultural Differences and Considerations When Initiating Insulin.
Rebolledo JA; Arellano R
Diabetes Spectr; 2016 Aug; 29(3):185-90. PubMed ID: 27574375
[No Abstract] [Full Text] [Related]
52. Ethnic differences in glycaemic control in people with type 2 diabetes mellitus living in Scotland.
Negandhi PH; Ghouri N; Colhoun HM; Fischbacher CM; Lindsay RS; McKnight JA; Petrie J; Philip S; Sattar N; Wild SH;
PLoS One; 2013; 8(12):e83292. PubMed ID: 24358273
[TBL] [Abstract][Full Text] [Related]
53. Exploring patient values in medical decision making: a qualitative study.
Lee YK; Low WY; Ng CJ
PLoS One; 2013; 8(11):e80051. PubMed ID: 24282518
[TBL] [Abstract][Full Text] [Related]
54. Display of human proinsulin on the Bacillus subtilis spore surface for oral administration.
Feng F; Hu P; Chen L; Tang Q; Lian C; Yao Q; Chen K
Curr Microbiol; 2013 Jul; 67(1):1-8. PubMed ID: 23380802
[TBL] [Abstract][Full Text] [Related]
55. Barriers in initiating insulin therapy in a South Asian Muslim community.
Ahmed US; Junaidi B; Ali AW; Akhter O; Salahuddin M; Akhter J
Diabet Med; 2010 Feb; 27(2):169-74. PubMed ID: 20546260
[TBL] [Abstract][Full Text] [Related]
56. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
[TBL] [Abstract][Full Text] [Related]
57. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
[TBL] [Abstract][Full Text] [Related]
58. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
[TBL] [Abstract][Full Text] [Related]
59. Barriers to insulin initiation and intensification and how to overcome them.
Kunt T; Snoek FJ
Int J Clin Pract Suppl; 2009 Oct; (164):6-10. PubMed ID: 19751453
[TBL] [Abstract][Full Text] [Related]
60. Demonstrating strategies for initiation of insulin therapy: matching the right insulin to the right patient.
Meneghini L
Int J Clin Pract; 2008 Aug; 62(8):1255-64. PubMed ID: 18705822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
